The signalling pathway, including GPR30, a non-classical ER, has been identified as a seven-transmembrane domain receptor and is highly significant in the adverse effects of low-dose BPA [ 36 ].
← all excerpts
The Current Findings on the Impact of Prenatal BPA Exposure on Metabolic Parameters: In Vivo and Epidemiological Evidence.
1
—
—